Dr. Tashanna Myers
Claim this profileBaystate Medical Center
Studies Cancer
Studies Ovarian Cancer
20 reported clinical trials
57 drugs studied
About Tashanna Myers
Education:
- Obtained an MD from the University of Massachusetts Medical School in 2016.
Experience:
- Completed a residency in Internal Medicine at Baystate Medical Center, serving as Chief Resident (2019-2020).
- Currently an Assistant Professor of Medicine at Tufts University School of Medicine.
Area of expertise
1Cancer
Stage IV
Stage III
PIK3CA positive
2Ovarian Cancer
Stage IV
Stage III
BRCA1 positive
Affiliated Hospitals
Clinical Trials Tashanna Myers is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting1 award Phase 2
More about Tashanna Myers
Clinical Trial Related4 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Tashanna Myers has experience with
- Paclitaxel
- Carboplatin
- Mirvetuximab Soravtansine
- Biospecimen Collection
- Olaparib
- Bevacizumab
Breakdown of trials Tashanna Myers has run
Cancer
Ovarian Cancer
Fallopian Tube Cancer
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tashanna Myers specialize in?
Tashanna Myers focuses on Cancer and Ovarian Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Tashanna Myers currently recruiting for clinical trials?
Yes, Tashanna Myers is currently recruiting for 9 clinical trials in Springfield Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Tashanna Myers has studied deeply?
Yes, Tashanna Myers has studied treatments such as Paclitaxel, Carboplatin, Mirvetuximab Soravtansine.
What is the best way to schedule an appointment with Tashanna Myers?
Apply for one of the trials that Tashanna Myers is conducting.
What is the office address of Tashanna Myers?
The office of Tashanna Myers is located at: Baystate Medical Center, Springfield, Massachusetts 01199 United States. This is the address for their practice at the Baystate Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.